Department Of Pediatric Oncology
Investigator
Luca Szalontay, MD
212-305-9770
ls3399@cumc.columbia.edu
(Biography not available)
| Condition |
Study Title |
| Pediatric Solid Tumors |
[ CLOSED ] A study in children, adolescents, and young adults recurrent or refractory solid tumors using study drug nivolumab |
| Cancer |
[ CLOSED ] Study of New Drug with Radiation Therapy in Children with Diffuse Intrinsic Pontine Gliomas (DIPG) Brain Stem Cancer |
| Cancer |
[ CLOSED ] Study of Nivolumab Monotherapy and Nivolumab in Combination with Ipilimumab in Subjects with Central Nervous System Malignancies |
| Solid Tumors |
[ CLOSED ] Study of VX15/2508 in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid Tumors |
| Cancer |
[ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years) |
| Cancer |
[ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21) |
| Leukemia |
[ CLOSED ] MLN4924 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (18 to 21 years old) |
| Childhood Leukemia |
[ CLOSED ] MLN4924 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (1 month to 17 years old) |
| Cancer |
[ CLOSED ] Study of Flotetuzumab for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML) |
| Childhood Leukemia |
[ CLOSED ] Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) |
| Leukemia |
[ CLOSED ] Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) |
